Gosset Ownership
Private
Employees
~20
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
BioLab Sciences General Information
BioLab Sciences develops and commercializes advanced wound care and regenerative medicine products based on human amniotic tissues and fluids. Their portfolio includes membrane wraps for wound coverage, liquid allografts rich in cytokines/growth factors for tissue repair, and the MyOwnSkin™ system for autologous skin grafting. Products are terminally sterilized with no live stem cells. The company has achieved CMS reimbursement codes for some offerings. Clinical results are not detailed publicly but the company highlights broad adoption in wound care settings.
Contact Information
Primary Industry
Therapeutic Medical Devices
Corporate Office
Mesa, Arizona
United States
United States
Drug Pipeline
Membrane Wrap Lite
CommercialKey Partnerships
Distributors such as Salus Medical, close collaboration with FDA/CMS on regulatory/reimbursement matters, no major pharma partnerships disclosed.
BioLab Sciences Funding
No funding data available
To view BioLab Sciences's complete valuation and funding history, request access »